{"id":"https://openalex.org/W2010148064","doi":"https://doi.org/10.1097/rlu.0000000000000758","title":"Therapeutic Algorithm Guided by Sequential 11C-Choline PET/CT in a Patient With Metastatic Castration-Resistant Prostate Cancer","display_name":"Therapeutic Algorithm Guided by Sequential 11C-Choline PET/CT in a Patient With Metastatic Castration-Resistant Prostate Cancer","publication_year":2015,"publication_date":"2015-03-04","ids":{"openalex":"https://openalex.org/W2010148064","doi":"https://doi.org/10.1097/rlu.0000000000000758","mag":"2010148064","pmid":"https://pubmed.ncbi.nlm.nih.gov/25742237"},"language":"en","primary_location":{"id":"doi:10.1097/rlu.0000000000000758","doi":"https://doi.org/10.1097/rlu.0000000000000758","is_oa":false,"landing_page_url":"https://doi.org/10.1097/rlu.0000000000000758","pdf_url":null,"source":{"id":"https://openalex.org/S1118231","display_name":"Clinical Nuclear Medicine","issn_l":"0363-9762","issn":["0363-9762","1536-0229"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Nuclear Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067309411","display_name":"JR Garcia Garzon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"JR Garcia Garzon","raw_affiliation_strings":["Conflicts of interest and sources of funding: none declared","the CETIR, Esplugues, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Conflicts of interest and sources of funding: none declared","institution_ids":[]},{"raw_affiliation_string":"the CETIR, Esplugues, Barcelona, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014263330","display_name":"Pere Bassa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pere Bassa","raw_affiliation_strings":["Conflicts of interest and sources of funding: none declared","the CETIR, Esplugues, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Conflicts of interest and sources of funding: none declared","institution_ids":[]},{"raw_affiliation_string":"the CETIR, Esplugues, Barcelona, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114189209","display_name":"Marina Soler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marina Soler","raw_affiliation_strings":["Conflicts of interest and sources of funding: none declared","the CETIR, Esplugues, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Conflicts of interest and sources of funding: none declared","institution_ids":[]},{"raw_affiliation_string":"the CETIR, Esplugues, Barcelona, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108236101","display_name":"Merc\u00e8 Moragas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Merce Moragas","raw_affiliation_strings":["Conflicts of interest and sources of funding: none declared","the CETIR, Esplugues, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Conflicts of interest and sources of funding: none declared","institution_ids":[]},{"raw_affiliation_string":"the CETIR, Esplugues, Barcelona, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034479345","display_name":"Elena Llinares","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elena Llinares","raw_affiliation_strings":["Conflicts of interest and sources of funding: none declared","the CETIR, Esplugues, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Conflicts of interest and sources of funding: none declared","institution_ids":[]},{"raw_affiliation_string":"the CETIR, Esplugues, Barcelona, Spain","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111503378","display_name":"Eduard Riera","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eduard Riera","raw_affiliation_strings":["Conflicts of interest and sources of funding: none declared","the CETIR, Esplugues, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Conflicts of interest and sources of funding: none declared","institution_ids":[]},{"raw_affiliation_string":"the CETIR, Esplugues, Barcelona, Spain","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2072,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.50909319,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":"40","issue":"7","first_page":"600","last_page":"601"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9775000214576721,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9775000214576721,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.010900000110268593,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":0.004800000227987766,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/11c-choline-pet-ct","display_name":"11C-choline PET/CT","score":0.9200000166893005},{"id":"https://openalex.org/keywords/metastatic-castration-resistant-prostate-cancer","display_name":"metastatic castration-resistant prostate cancer","score":0.9269999861717224},{"id":"https://openalex.org/keywords/treatment-algorithm","display_name":"treatment algorithm","score":0.5910000205039978},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9049999713897705},{"id":"https://openalex.org/keywords/abiraterone-acetate","display_name":"abiraterone","score":0.9940000176429749},{"id":"https://openalex.org/keywords/cabazitaxel","display_name":"cabazitaxel","score":1.0},{"id":"https://openalex.org/keywords/androgen-deprivation-therapy","display_name":"androgen deprivation therapy","score":0.8479999899864197},{"id":"https://openalex.org/keywords/treatment-resistance","display_name":"treatment resistance","score":0.777999997138977},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.6129999756813049}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.94428551197052},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.8336478471755981},{"id":"https://openalex.org/C2779256933","wikidata":"https://www.wikidata.org/wiki/Q58929","display_name":"Castration","level":3,"score":0.6271518468856812},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.44637709856033325},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35580503940582275},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.3523695766925812},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.326785683631897},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.0842415988445282}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000465","descriptor_name":"Algorithms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002250","descriptor_name":"Carbon Radioisotopes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002794","descriptor_name":"Choline","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014057","descriptor_name":"Tomography, X-Ray Computed","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019275","descriptor_name":"Radiopharmaceuticals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049268","descriptor_name":"Positron-Emission Tomography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D064129","descriptor_name":"Prostatic Neoplasms, Castration-Resistant","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":true},{"descriptor_ui":"D064129","descriptor_name":"Prostatic Neoplasms, Castration-Resistant","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D064129","descriptor_name":"Prostatic Neoplasms, Castration-Resistant","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D064847","descriptor_name":"Multimodal Imaging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/rlu.0000000000000758","doi":"https://doi.org/10.1097/rlu.0000000000000758","is_oa":false,"landing_page_url":"https://doi.org/10.1097/rlu.0000000000000758","pdf_url":null,"source":{"id":"https://openalex.org/S1118231","display_name":"Clinical Nuclear Medicine","issn_l":"0363-9762","issn":["0363-9762","1536-0229"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Nuclear Medicine","raw_type":"journal-article"},{"id":"pmid:25742237","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25742237","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical nuclear medicine","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W1966225993","https://openalex.org/W1997042762","https://openalex.org/W2020359117","https://openalex.org/W2091384457","https://openalex.org/W2093941725","https://openalex.org/W2099992087","https://openalex.org/W2132315278","https://openalex.org/W2141427476","https://openalex.org/W2399806230"],"related_works":["https://openalex.org/W2315729659","https://openalex.org/W2909753989","https://openalex.org/W3119652089","https://openalex.org/W2963006571","https://openalex.org/W4287218199","https://openalex.org/W2941414418","https://openalex.org/W2359697729","https://openalex.org/W7097641905","https://openalex.org/W2141427476","https://openalex.org/W1941419950"],"abstract_inverted_index":{"Antiandrogen":[0],"therapy":[1,7],"alone":[2],"or":[3,64],"combined":[4],"with":[5,18,46,59,73,76],"radical":[6],"is":[8],"the":[9,83,91],"first":[10],"choice":[11],"in":[12],"diagnosis":[13],"and":[14,55],"recurrence":[15],"of":[16,90],"patients":[17,23],"metastatic":[19,37],"prostate":[20,39],"cancer.":[21],"However,":[22],"on":[24],"androgen":[25],"deprivation":[26],"frequently":[27],"show":[28],"treatment":[29],"resistance.":[30],"In":[31],"recent":[32],"years,":[33],"new":[34],"treatments":[35],"for":[36,52,81,86],"castration-resistant":[38],"cancer":[40],"have":[41,48,66],"been":[42,68],"developed.":[43],"Clinical":[44],"studies":[45],"docetaxel":[47],"shown":[49],"its":[50],"usefulness":[51],"first-line":[53],"therapy,":[54],"different":[56],"therapeutic":[57,92],"algorithms":[58],"second-line":[60],"drugs":[61],"like":[62],"abiraterone":[63],"cabazitaxel":[65],"also":[67],"proposed.":[69],"Sequential":[70],"metabolic":[71],"study":[72],"PET/CT":[74],"imaging":[75],"\u00b9\u00b9C-choline":[77],"may":[78],"be":[79],"important":[80],"assessing":[82],"right":[84],"moment":[85],"administration":[87],"each":[88],"one":[89],"options.":[93]},"counts_by_year":[{"year":2016,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}